Equities Research Analysts’ updated eps estimates for Monday, September 23rd:
Affirm (NASDAQ:AFRM) had its price target increased by Barclays PLC from $50.00 to $54.00. They currently have an overweight rating on the stock.
Bitfarms (NASDAQ:BITF) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $4.00 target price on the stock.
Context Therapeutics (NASDAQ:CNTX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $6.00 price target on the stock.
Citigroup Inc. assumed coverage on shares of Hewlett Packard Enterprise (NYSE:HPE). The firm issued a neutral rating and a $20.00 target price on the stock.
Heart Test Laboratories (NASDAQ:HSCS) had its buy rating reaffirmed by analysts at Ascendiant Capital Markets. The firm currently has a $15.00 target price on the stock.
Juniper Networks (NYSE:JNPR) had its neutral rating reiterated by analysts at Citigroup Inc.. The firm currently has a $40.00 price target on the stock.
Lundin Gold (TSE:LUG) was downgraded by analysts at Raymond James from an outperform rating to a market perform rating. Raymond James currently has C$29.00 price target on the stock, up from their previous price target of C$25.00.
Meridian Mining UK Societas (CVE:MNO) was downgraded by analysts at Raymond James from a strong-buy rating to an outperform rating. They currently have C$1.50 target price on the stock.
MINISO Group (NYSE:MNSO) was downgraded by analysts at Bank of America Co. from a buy rating to an underperform rating.
MINISO Group (NYSE:MNSO) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc..
MultiPlan (NYSE:MPLN) had its price target reduced by Citigroup Inc. from $17.20 to $10.00. Citigroup Inc. currently has a neutral rating on the stock.
Nano-X Imaging (NASDAQ:NNOX) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $14.00 price target on the stock.
Perrigo (NYSE:PRGO) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a $30.00 price target on the stock, down from their previous price target of $50.00.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. They currently have a $1,200.00 target price on the stock.
Ventyx Biosciences (NASDAQ:VTYX) had its neutral rating reissued by analysts at HC Wainwright. The firm currently has a $6.00 price target on the stock.
Receive News & Ratings for Affirm Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.